{"DataElement":{"publicId":"6183996","version":"1","preferredName":"Cutaneous Melanoma AJCC Edition 8 Clinical Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for skin melanoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"CMEL_AJC8_CLN_N_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3357535","version":"1","preferredName":"Cutaneous Melanoma Clinical N Stage","preferredDefinition":"A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma._Having to do with the examination and treatment of patients._One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"2431290v1.0:2428496v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2431290","version":"1","preferredName":"Cutaneous Melanoma","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.","longName":"C3510","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma","conceptCode":"C3510","definition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF3BE-971D-3B79-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-654C-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt moved to NCI Standards Context. Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6183943","version":"1","preferredName":"Cutaneous Melanoma American Joint Committee on Cancer Edition 8 Clinical N Category","preferredDefinition":"A clinical finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes. The TNM clinical and pathologic regional lymph nodes classifications of cutaneous melanoma are not the same. TNM clinical regional lymph nodes findings are based on clinical/radiographic examination of the regional lymph nodes (clinically detected regional lymph node metastasis). (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6183943v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3c","valueDescription":"Cutaneous Melanoma cN3c TNM Finding v8","ValueMeaning":{"publicId":"6183975","version":"1","preferredName":"Cutaneous Melanoma cN3c TNM Finding v8","longName":"6183975","preferredDefinition":"Cutaneous melanoma with two or more clinically detected nodal metastases and/or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN3c TNM Finding v8","conceptCode":"C136920","definition":"Cutaneous melanoma with two or more clinically detected nodal metastases and/or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-44E7-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-4500-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N3b","valueDescription":"Cutaneous Melanoma cN3b TNM Finding v8","ValueMeaning":{"publicId":"6183977","version":"1","preferredName":"Cutaneous Melanoma cN3b TNM Finding v8","longName":"6183977","preferredDefinition":"Cutaneous melanoma with four or more nodal metastases, at least one of which was clinically detected, or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN3b TNM Finding v8","conceptCode":"C136919","definition":"Cutaneous melanoma with four or more nodal metastases, at least one of which was clinically detected, or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-450D-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-4526-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N3","valueDescription":"Cutaneous Melanoma cN3 TNM Finding v8","ValueMeaning":{"publicId":"6183979","version":"1","preferredName":"Cutaneous Melanoma cN3 TNM Finding v8","longName":"6183979","preferredDefinition":"Cutaneous melanoma with four or more tumor-involved nodes or in-transit satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes without or with in-transit, satellite, and/or microsatellite metastases. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN3 TNM Finding v8","conceptCode":"C136918","definition":"Cutaneous melanoma with four or more tumor-involved nodes or in-transit satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes without or with in-transit, satellite, and/or microsatellite metastases. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-4533-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-454C-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N2c","valueDescription":"Cutaneous Melanoma cN2c TNM Finding v8","ValueMeaning":{"publicId":"6183981","version":"1","preferredName":"Cutaneous Melanoma cN2c TNM Finding v8","longName":"6183981","preferredDefinition":"Cutaneous melanoma with one clinically detected metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN2c TNM Finding v8","conceptCode":"C136917","definition":"Cutaneous melanoma with one clinically detected metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-4559-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-4572-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N2b","valueDescription":"Cutaneous Melanoma cN2b TNM Finding v8","ValueMeaning":{"publicId":"6183983","version":"1","preferredName":"Cutaneous Melanoma cN2b TNM Finding v8","longName":"6183983","preferredDefinition":"Cutaneous melanoma with two or three nodal metastases at least one of which was clinically detected. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN2b TNM Finding v8","conceptCode":"C136916","definition":"Cutaneous melanoma with two or three nodal metastases at least one of which was clinically detected. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-457F-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-4598-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N2","valueDescription":"Cutaneous Melanoma cN2 TNM Finding v8","ValueMeaning":{"publicId":"6183985","version":"1","preferredName":"Cutaneous Melanoma cN2 TNM Finding v8","longName":"6183985","preferredDefinition":"Cutaneous melanoma with two or three tumor-involved nodes or in-transit satellite, and/or microsatellite metastases with one tumor-involved node. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN2 TNM Finding v8","conceptCode":"C136915","definition":"Cutaneous melanoma with two or three tumor-involved nodes or in-transit satellite, and/or microsatellite metastases with one tumor-involved node. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-45A5-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-45BE-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N1c","valueDescription":"Cutaneous Melanoma cN1c TNM Finding v8","ValueMeaning":{"publicId":"6183987","version":"1","preferredName":"Cutaneous Melanoma cN1c TNM Finding v8","longName":"6183987","preferredDefinition":"Cutaneous melanoma with no regional lymph node disease. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN1c TNM Finding v8","conceptCode":"C136914","definition":"Cutaneous melanoma with no regional lymph node disease. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-45CB-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-45E4-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N1b","valueDescription":"Cutaneous Melanoma cN1b TNM Finding v8","ValueMeaning":{"publicId":"6183989","version":"1","preferredName":"Cutaneous Melanoma cN1b TNM Finding v8","longName":"6183989","preferredDefinition":"Cutaneous melanoma with one clinically detected nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN1b TNM Finding v8","conceptCode":"C136913","definition":"Cutaneous melanoma with one clinically detected nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-45F1-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-460A-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N1","valueDescription":"Cutaneous Melanoma cN1 TNM Finding v8","ValueMeaning":{"publicId":"6183991","version":"1","preferredName":"Cutaneous Melanoma cN1 TNM Finding v8","longName":"6183991","preferredDefinition":"Cutaneous melanoma with one tumor-involved node or in-transit satellite, and/or microsatellite metastases with no tumor-involved nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN1 TNM Finding v8","conceptCode":"C136912","definition":"Cutaneous melanoma with one tumor-involved node or in-transit satellite, and/or microsatellite metastases with no tumor-involved nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-4617-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-4630-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"N0","valueDescription":"Cutaneous Melanoma cN0 TNM Finding v8","ValueMeaning":{"publicId":"6183993","version":"1","preferredName":"Cutaneous Melanoma cN0 TNM Finding v8","longName":"6183993","preferredDefinition":"Cutaneous melanoma without regional lymph node metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cN0 TNM Finding v8","conceptCode":"C136911","definition":"Cutaneous melanoma without regional lymph node metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-463D-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-4656-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"},{"value":"NX","valueDescription":"Cutaneous Melanoma cNX TNM Finding v8","ValueMeaning":{"publicId":"6183995","version":"1","preferredName":"Cutaneous Melanoma cNX TNM Finding v8","longName":"6183995","preferredDefinition":"Cutaneous melanoma in which the regional lymph nodes are not assessed (e.g., sentinel lymph node biopsy is not performed, regional lymph nodes were previously removed for another reason). Exception: pathological N category is not required for T1 melanomas, use cN. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma cNX TNM Finding v8","conceptCode":"C136910","definition":"Cutaneous melanoma in which the regional lymph nodes are not assessed (e.g., sentinel lymph node biopsy is not performed, regional lymph nodes were previously removed for another reason). Exception: pathological N category is not required for T1 melanomas, use cN. Presence of in-transit, satellite, and/or microsatellite metastases: No.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A92FFD-4663-42A2-E053-F662850A8F5B","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"69A92FFD-467C-42A2-E053-F662850A8F5B","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6183942","version":"1","preferredName":"Cutaneous Melanoma Clinical Regional Lymph Nodes TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A clinical finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes. The TNM clinical and pathologic regional lymph nodes classifications of cutaneous melanoma are not the same. TNM clinical regional lymph nodes findings are based on clinical/radiographic examination of the regional lymph nodes (clinically detected regional lymph node metastasis). (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C136909:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma Clinical Regional Lymph Nodes TNM Finding v8","conceptCode":"C136909","definition":"A clinical finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes. The TNM clinical and pathologic regional lymph nodes classifications of cutaneous melanoma are not the same. TNM clinical regional lymph nodes findings are based on clinical/radiographic examination of the regional lymph nodes (clinically detected regional lymph node metastasis). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69ACF0A0-54E6-214C-E053-F662850A42CB","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"ONEDATA","dateModified":"2018-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"69ACF0A0-54F7-214C-E053-F662850A42CB","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"TAYLORT","dateModified":"2018-04-19","changeDescription":"4/12/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000090","version":"1","longName":"Cutaneous Melanoma","context":"NCI Standards"},{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical N category","type":"Preferred Question Text","description":"Clinical N category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"69ADE015-8C06-1870-E053-F662850A92AB","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"TAYLORT","dateModified":"2018-04-19","changeDescription":"4/12/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}